Lupus skin study reveals why patients skip meds
NCT ID NCT06506214
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at 202 adults with cutaneous lupus to see how well they follow their treatment plans and how satisfied they are with their care. Researchers used questionnaires to measure adherence, beliefs about medicine, anxiety, depression, and quality of life. The goal is to understand what factors—like fear of side effects or the doctor-patient relationship—affect treatment adherence.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
202 people
The number who actually took part.
- Started
-
Oct 2022
- Finished
-
Jan 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adult patients with cutaneous lupus (pure cutaneous or subacute) diagnosed by a dermatologist and under local and/or systemic treatment for cutaneous lupus.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients with cutaneous lupus (pure cutaneous or subacute) diagnosed by a dermatologist and under local and/or systemic treatment for cutaneous lupus * No opposition to participation * Patient able to complete the questionnaires * Adult patient Exclusion Criteria: * Systemic lupus with multiple visceral involvement * Cognitive or psychiatric disorders preventing the smooth running of the study * Pregnant woman * Patient under guardianship/curatorship or safeguard of justice
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cutaneous lupus are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
APHP Hôpital Saint-Louis
Paris, 75010, France
-
Hôpital Tenon
Paris, 75020, France
-
University Hospital Montpellier
Montpellier, 34090, France
-
University Hospital Toulouse
Toulouse, 31400, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict the path of chronic skin disease?
- Can a skin biopsy tell your doctor which treatment will work?
- Scientists launch hunt for clues in autoimmune skin diseases
- New hope for lupus skin flares? drug shows promise in early trial
- Lupus patients needed for Long-Term study
- New registry aims to unlock secrets of autoimmune disease in pregnancy